| 000 | 01813 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515124241.0 | ||
| 264 | 0 | _c20080812 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/j.amjcard.2008.02.093 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJensen, Lisette Okkels | |
| 245 | 0 | 0 |
_aIntravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cJul 2008 |
||
| 300 |
_a19-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Restenosis _xdiagnostic imaging |
| 650 | 0 | 4 | _aDiabetes Mellitus |
| 650 | 0 | 4 | _aDiabetic Angiopathies |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 | _aUltrasonography, Interventional |
| 700 | 1 | _aMaeng, Michael | |
| 700 | 1 | _aMintz, Gary S | |
| 700 | 1 | _aChristiansen, Evald Hoej | |
| 700 | 1 | _aHansen, Knud Noerregaard | |
| 700 | 1 | _aGalloe, Anders | |
| 700 | 1 | _aKelbaek, Henning | |
| 700 | 1 | _aHansen, Henrik Steen | |
| 700 | 1 | _aJoergensen, Erik | |
| 700 | 1 | _aLassen, Jens Flensted | |
| 700 | 1 | _aThuesen, Leif | |
| 700 | 1 | _aThayssen, Per | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 102 _gno. 1 _gp. 19-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjcard.2008.02.093 _zAvailable from publisher's website |
| 999 |
_c18056156 _d18056156 |
||